gastric electrical stimulator enterra® therapy system (Enterra Feed Corporation)
90
Structured Review
Enterra Feed Corporation
gastric electrical stimulator enterra® therapy system
Gastric Electrical Stimulator Enterra® Therapy System, supplied by Enterra Feed Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gastric+electrical+stimulation/enterra+gastric+pacemaker/pm38460084-44-8-10
Average 90 stars, based on 1 article reviews
Gastric Electrical Stimulator Enterra® Therapy System, supplied by Enterra Feed Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gastric+electrical+stimulation/enterra+gastric+pacemaker/pm38460084-44-8-10
Average 90 stars, based on 1 article reviews
gastric electrical stimulator enterra® therapy system - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Validation of noninvasive body-surface gastric mapping for detecting gastric slow-wave spatiotemporal features by simultaneous serosal mapping in porcine. Article Snippet: Gastric disorders are increasingly prevalent, but reliable noninvasive tools to objectively assess gastric function are lacking.. Body-surface gastric mapping (BSGM) is a noninvasive method for the detection of gastric electrophysiological features, which are correlated with symptoms in patients with gastroparesis and functional dyspepsia.. Previous studies have validated the relationship between serosal and cutaneous recordings from limited number of channels. Article Title: Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives. Article Snippet: Introduction: Gastroparesis is an important clinical disorder characterised by delayed gastric emptying in the absence of mechanical outlet obstruction.. Idiopathic, diabetes and postsurgical causes represent the most common aetiologies.. The condition commonly manifests as upper gastrointestinal symptoms, including nausea, vomiting, postprandial fullness, early satiety, abdominal pain and bloating. Article Title: Enteric neuromuscular pathology update. Article Snippet: This issue of Gastroenterology Clinics of North America is focused on challenges faced in everyday clinical practice.. Thus rather than reviewing the evolving research literature that details the many experimental models of enteric neuromuscular disease, this article considers the problems faced by the practicing pathologist, who, faced with a single tight-focus histologic “snapshot” of surgically derived tissue must decide whether disease of nerve, smooth muscle, or interstitial cells of Cajal (ICC) are present.. This raises several technical and interpretational challenges (Box 1). Article Title: Gastrointestinal autonomic neuropathy in diabetes. Article Snippet: Gastrointestinal autonomic neuropathy represents an important and diverse, but poorly appreciated, manifestation of diabetic autonomic neuropathy that impacts negatively on quality of life.. There is no test to assess gastrointestinal autonomic nerve damage directly in humans; cardiovascular autonomic reflex tests are often used as a surrogate, but are suboptimal.. Gastrointestinal symptoms are common in diabetes, but usually correlate only weakly with disordered motility. Article Title: Gastric Electrical Stimulator for Treatment of Gastroparesis. Article Snippet: Gastroparesis is a syndrome of delayed gastric emptying in which patients experience a variety of symptoms, including nausea, vomiting, abdominal pain, and early satiety.. This delayed gastric emptying can be due to abnormal myoelectrical activity or abnormal gastric motility, with 2 common causes being diabetes mellitus and prior gastric surgery with vagotomy.. Treatment options have evolved over the years. Article Title: Ameliorating effects of sacral neuromodulation on gastric and small intestinal dysmotility mediated via a sacral afferent-vagal efferent pathway. Article Snippet: Gastrointestinal (GI) motility disorders are common in conditions such as functional dyspepsia (FD), gastroparesis (GP), intestinal pseudo-obstructions, and postoperative ileus.1-5 The pathophysiology of GP and FD is often complex and multifactorial, including impaired gastric accommodation, antral dysmotility, and visceral hypersensitivity.2 Approximately 20%-40% of diabetic patients develop autonomic nervous system dysfunctions, which are often associated with Received: 6 December 2019 | Revised: 4 February 2020 | Accepted: 18 February 2020 DOI: 10.1111/nmo.13837 Article Title: Wisconsin's Enterra Therapy Experience: A multi-institutional review of gastric electrical stimulation for medically refractory gastroparesis. Article Snippet: Background: Gastric electrical stimulation is a treatment for symptoms of diabetic or idiopathic gastroparesis refractory to medical management.. We sought to evaluate the outcomes of gastric electrical stimulation in the state of Wisconsin during a more than 10-year period.. Methods: Data were collected prospectively from patients undergoing implantation of the gastric electrical stimulation to initiate gastric electrical stimulation therapy at two Wisconsin institutions from 2005– 2017. Article Title: Gastroparesis: pathogenesis, diagnosis and management. Article Snippet: | Gastroparesis is a prevalent condition that produces symptoms of delayed gastric emptying in the absence of physical blockage.. The most common etiologies of gastroparesis are idiopathic, diabetic, and postsurgical disease, although some cases stem from autoimmune, paraneoplastic, neurologic or other conditions.. Histologic examination of gastric tissues from patients with severe gastroparesis reveals heterogeneous and inconsistent defects in the morphology of enteric neurons, smooth muscle and interstitial cells of Cajal, and increased levels of inflammatory cells. |